Summary
Health Secretary Robert F. Kennedy Jr. announced that the U.S. government will stop funding $500 million for new mRNA vaccine projects. The decision affects contracts with companies like Moderna, Pfizer, and Sanofi, as the focus shifts to developing what are viewed as safer vaccine types.
Key Facts
- The U.S. government is withdrawing $500 million in funding for new mRNA vaccines.
- Affected contracts include a significant award to Moderna for H5N1 bird flu vaccines.
- This change is part of a broader shift to focus on safer vaccine platforms.
- Contracts already in the final stages may continue to preserve investments.
- The stated reason for stopping the funding is that current mRNA vaccines do not effectively prevent upper respiratory infections.
- Infectious disease experts argue the goal of vaccines should be to reduce severe illness rather than block all infections.
- The move follows Kennedy's prior proposals to change federal vaccine policies and liability protections for vaccine makers.
- Some states led by conservative figures have been skeptical of mRNA vaccines and public health efforts during the COVID-19 pandemic.
